Opinion|Videos|August 12, 2026

Weighing Surgical Versus Medical Management in Endometriosis

"Weighing Surgical Versus Medical Management in Endometriosis" takes up the question of when a patient's endometriosis care should shift from medicine to the operating room.

"Weighing Surgical Versus Medical Management in Endometriosis" takes up the question of when a patient's endometriosis care should shift from medicine to the operating room.

Dr. Davitt discusses the most significant challenges in surgical management of endometriosis and when he chooses surgery over medical therapy. He explains that his surgical approach is guided by meeting each patient where they are in their diagnostic and treatment journey, since the right path will differ for every individual. Personally, his biggest challenge is that he can never promise a specific surgical outcome, given the variability in how disease presents and the other pain generators a patient may have. He is careful never to tell a patient their pain will be 100% resolved after surgery, instead building a plan grounded in available evidence and managing expectations honestly. He also points to the cost of surgery itself, including anesthesiologist fees, facility fees, post-operative medications, and the time a patient loses to the surgical day and recovery, as a major barrier. He notes that data comparing medical-first and surgery-first pathways show little cost difference across populations overall, but for individual patients the expense can still be an enormous obstacle he confronts daily. Dr. Kho then walks through when surgery specifically becomes the right choice: when a patient wants a definitive diagnosis before pursuing treatment, when there's a contraindication to hormonal options, when a patient has already failed multiple medical or non-medical therapies such as physical therapy and still has persistent pain, or when fertility goals point that direction. The discussion closes on ovarian endometriomas, noting that lesions larger than roughly three to four centimeters generally will not resolve with medical therapy alone. Because only about 15% of the time is disease isolated to the ovary, the panel cautions that these patients often have associated deep disease and fibrosis near the ureter, which can require far more extensive surgical excision than the ovarian finding alone would suggest.

Our next episode, "Why Estrogen Suppression Anchors Endometriosis Treatment," turns to why estrogen suppression sits at the center of every medical treatment plan.


Latest CME